Salta al contenuto principale
Passa alla visualizzazione normale.

FABIO SALVATORE PALUMBO

NEW POLYSACCHARIDE-POLYAMINOACID HYDROGELS: A SUITABLE STRATEGY FOR COLON-SPECIFIC DRUG DELIVERY

  • Autori: Pitarresi, G.; Casadei, M.; Mandracchia, D.; Paolicelli, P.; Palumbo, F.; Giammona, G.
  • Anno di pubblicazione: 2007
  • Tipologia: Proceedings (TIPOLOGIA NON ATTIVA)
  • Parole Chiave: Dextran; α,β-Poly(N-2-hydroxyethyl)-DL-aspartamide; Photocrosslinking; Biodegradable hydrogels; Colon drug delivery

Abstract

The aim of this study was to prepare and characterize novel hydrogels with polysaccharide–polyaminoacid structure, able to undergo an enzymatic hydrolysis in the colon and potentially useful for treating inflammatory bowel diseases (IBD). Starting materials were methacrylated dextran (DEX-MA) and methacrylated α,β-poly(N-2-hydroxyethyl)-DL-aspartamide (PHM). These polymers were photocrosslinked by exposure of their aqueous solutions at 313 nm without photoinitiators. Different samples, shaped as microparticles, were obtained as a function of polymer concentration and irradiation time. FT-IR analysis confirmed the occurrence of a co-crosslinking between DEX-MA and PHM in all experimental conditions. Size analysis evidenced a narrow particle distribution and swelling studies, performed in twice-distilled water and simulated gastrointestinal fluids, showed a good affinity of these hydrogels towards the aqueous medium. DEX-MA/PHM based hydrogels undergo a negligible chemical hydrolysis, whereas they are partially degraded by dextranase. In vitro biological assays showed cell compatibility of these samples. Beclomethasone dipropionate (BDP), a drug recently proposed for the treatment of IBD was entrapped into a DEX-MA/PHM based hydrogel and its release was evaluated in the absence or in the presence of dextranase. Obtained release profiles suggest the potential use of BDP loaded DEX-MA/PHM based hydrogels for the treatment of IBD.